BAXTER ADMITS FAULT IN HEPARIN CONTAMINATION
Baxter International Inc. has assumed responsibility in the nation-wide heparin contamination that endangered the health of thousands. Though they have admitted fault for their role in the distribution of the defective drug, Baxter denies any part in “deliberate” contamination.
Reports of serious allergic reactions and deaths associated with heparin doses began late in December of 2007. By January, there were sufficient reports of adverse reactions to prompt Baxter to recall about 10 percent of their annual production of heparin.
The contamination was finally linked to heparin manufacturing plants in China last March. Since then, there have been numerous investigations to find the responsible parties, since Chinese drug manufacturing is significantly less regulated than that in the United States.
The defective drug lawyers at Cappolino Dodd Krebs LLP take on cases of defective drugs and injury caused by negligent companies. Have you been injured due to faulty pharmaceuticals? call our Texas office today.